ABI considers changes to new CI definitions

When the ABI published the definitions in April, it was decided two rare bone marrow disorders should be defined as pre-malignant and become covered by critical illness (CI) policies at the point they turn malignant. But subsequent medical opinions have suggested the disorders should be defined as malignant, and the ABI’s protection committee is therefore weighing up the opinions with a view to allowing insurers to make changes to the CI definitions. Nick Kirwan, head of the protection committee, says the disorders are extremely rare but the ABI wants to make sure the definitions are ...